Karyopharm Therapeutics Inc. and Clinipace Worldwide Announce Preferred Provider Agreement

Clinipace Worldwide announced it has entered into a preferred provider agreement with Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancOriginal Article